IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.